Mirtazapine | 米氮平 | 6-Azamianserin | NaSSA Agent | AmBeed-信号通路专用抑制剂

首页 / / / / Mirtazapine

米尔塔扎平 /Mirtazapine {[allProObj[0].p_purity_real_show]}

货号：A266101 同义名： 米氮平 / 6-Azamianserin;Org3770

Mirtazapine is a potent tetracyclic antidepressant.

Mirtazapine 化学结构
CAS号：85650-52-8

Mirtazapine 3D分子结构
CAS号：85650-52-8

规格	价格	会员价	库存	数量
{[ item.pr_size ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]}	{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]}	现货	咨询	- +

购物车0 收藏询单

sales@ambeed.cn tech@ambeed.cn 400-920-2911 产品手册产品订购技术咨询
快速发货顺丰冷链运输，1-2 天到达

品质保证

技术支持

免费溶解

Mirtazapine 纯度/质量文件产品仅供科研

货号：A266101 标准纯度： {[allProObj[0].p_purity_real_show]} 产品说明书

批次查询：批次纯度: COA SDS NMR HPLC CNMR LC-MS

全球学术期刊中引用的产品: • Nat. Biomed. Eng., 2024, 8, 1412-1424. Ambeed. [ A538667 , A631746 ]; • JMC, 2024. Ambeed. [ A833302 , A475501 , A341986 , A356070 ]; • BMC Cancer, 2024, 24(1): 1415. Ambeed. [ A809692 , A209020 ]; • J. Am. Soc. Mass Spectrom., 2024, 35(12): 3192-3202. Ambeed. [ A166127 , A902473 , A753371 , A961334 , A292945 , A230770 , A300620 , A1114580 , A1159765 , A206238 ]; • PloS One, 2024, 19(11): e0308060. Ambeed. [ A302917 ]; 更多 >

5-羟色胺受体亚型比较

产品名称	5-HT ↓ ↑	5-HT1 ↓ ↑	5-HT2 ↓ ↑	5-HT3 ↓ ↑	5-HT5 ↓ ↑	5-HT6 ↓ ↑	5-HT7 ↓ ↑	其他靶点	纯度
Desvenlafaxine	++ 5-HT, Ki: 40.2 nM								98%
Lamotrigine	+ 5-HT (rat brain synaptosomes), IC50: 474 μM 5-HT (human platelets), IC50: 240 μM								98%
Venlafaxine	✔								98%
Fluvoxamine maleate	✔								99%
Iloperidone	✔								98%
Ziprasidone HCl	✔								98+%
Atomoxetine HCI	+ 5-HT, Ki: 77 nM								98%
Dapoxetine HCl	✔								97%
Trazodone	✔								98+%
Clomipramine HCl	✔								98%
Mirtazapine	✔								99+%
Escitalopram oxalate	+++ 5-HT, Ki: 0.89 nM								97%
Duloxetine	✔								98+%
Sertraline HCl	++ 5-HT, Ki: 13 nM								98%
Citalopram HBr	+++ serotonin reuptake, IC50: 1.8 nM								98%
Latrepirdine 2HCl	✔							GluR	98%
Fluoxetine HCl	✔								99.5%
Paroxetine hydrochloride	✔							AChR	97%
BMY 7378		++ 5-HT1D, pIC50: 5.9 5-HT1A, pIC50: 6.4	+ 5-HT2, pIC50: 5.5						97%
Flibanserin		+++ 5-HT1A, Ki: 1 nM	+ 5-HT2A, Ki: 49 nM						98%
LY310762		+ 5-HT1D, Ki: 249 nM							99%+
Cyclobenzaprine HCI			✔						99%
Blonanserin			+++ 5-HT2, Ki: 3.98 nM						98% HPLC
Cyproheptadine HCl			++++ 5-HT2, IC50: 0.6 nM						99+%
Olanzapine			✔						99+%
Pimavanserin hemitartrate			+++ 5-HT2A, pIC50: 8.7						99%
Ketanserin			+++ 5-HT2C (Rat), Ki: 50 nM 5-HT2C (Human), Ki: 2.5 nM						99%+
Loxapine succinate			++ 5-HT2 (human), Ki: 6.8 nM 5-HT2 (bovine), Ki: 6.6 nM						99%
Agomelatine			✔						98%
Clozapine			✔						98%
Amitriptyline			+ 5-HT2, Ki: 235 nM					SERT	98%
PRX-08066 maleate			+++ 5-HT2B, IC50: 3.4 nM						98+%
RS-127445			++++ 5-HT2B, pKi: 9.5 5-HT2B, pIC50: 10.4						99%+
Sarpogrelate HCl			++++ 5-HT2C, Kd: 1.1 nM 5-HT2A, Kd: 2.1 nM						98%
Tropisetron				✔					99%
Palonosetron				✔					98+%
Ramosetron HCl				++++ 5-HT3 receptor, Ki: 0.091 nM					98%
Ondansetron				✔					99%
Granisetron				✔					98%
Alosetron HCl				✔					98%
Ondansetron hydrochloride dihydrate				✔					98%
VUF10166				++++ 5-HT3A, Ki: 0.04 nM 5-HT3AB, Ki: 22 nM					99%+
Azasetron hydrochloride				++++ 5-HT3, IC50: 0.33 nM					98%
Asenapine maleate		+++ 5-HT1A, pKi: 8.6 5-HT1B, pKi: 8.4	++++ 5-HT2C, pKi: 10.46 5-HT2A, pKi: 9.75		+++ 5-HT5A, pKi: 8.84	++++ 5-HT6, pKi: 9.6	++++ 5-HT7, pKi: 9.94		97%
Risperidone		++ 5-HT1B, Ki: 14.9 nM 5-HT1D, Ki: 84.6 nM	++++ 5-HT2A, Ki: 61.9 nM 5-HT2C, Ki: 12 nM		+ 5-HT5A, Ki: 206 nM		++ 5-HT7, Ki: 6.6 nM		98%
SB 271046 HCl						+++ 5-HT6, pKi: 8.92			99%+
Intepirdine						++++ 5-HT6, pKi: 9.63			99%+
SB-269970 HCl							++ 5-HT7, pKi: 8.3		98+%
BRL 15572		++ 5-HT1D, pKi: 6 5-HT1B, pKi: 6.1	++ 5-HT2B, pKi: 6.2 5-HT2A, pKi: 6.6			+ 5-HT6, pKi: 5.9	+ 5-HT7, pKi: 6.3		98%
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多，抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用，但抑制强度暂时没有相关数据。

Mirtazapine 生物活性

靶点

5-HT

描述

Mirtazapine is a noradrenergic and specific serotonergic antidepressant (NaSSA) that acts by antagonizing the adrenergic alpha2-autoreceptors and alpha2-heteroreceptors as well as by blocking 5-HT2 and 5-HT3 receptors. It enhances the release of norepinephrine and 5-HT1A-mediated serotonergic transmission. In vitro studies suggest that mirtazapine is unlikely to cause clinically significant drug-drug interactions. Dry mouth, sedation, and increases in appetite and body weight are the most common adverse effects. Mirtazapine also appears to be useful in patients suffering from depression comorbid with anxiety symptoms and sleep disturbance. It seems to be safe and effective during long-term use^[3]. Mirtazapine seems to be safe in pregnancy, especially regarding incidence of congenital malformations^[4]. A large-scale controlled evaluation is warranted to substantiate clinical utility of off-label use of mirtazapine (7.5 mg) for patients with AAA (antipsychotic-associated akathisia) ^[5]. Mirtazapine significantly improved both nausea and vomiting in gastroparetics after 2 and 4 weeks of treatment. Side effects led to treatment self-cessation in a fifth of patients^[6].

Mirtazapine 临床研究

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点
NCT01216371	Renal Cell Carcinoma ... 展开 >> Pulmonary Metastases 收起 <<	Phase 2	Unknown	October 2015	Germany ... 展开 >> Universitätsmedizin Charité Berlin Not yet recruiting Berlin, Germany, 10117 Contact: Steffen Weikert, Priv. Doz. Dr. med. 030/84 45-40 84 Principal Investigator: Steffen Weikert, Priv. Doz. Dr. med. Sub-Investigator: Kempkensteffen Carsten, Dr. med. Sub-Investigator: Jonas Busch, Dr. med. Sub-Investigator: Jan Gregor, Dr. med. Sub-Investigator: Jens Neudecker, Dr. med. Sub-Investigator: Jens C. Rückert, Dr. med. Sub-Investigator: Gertrud Feldmann Franziskus Krankenhaus Not yet recruiting Berlin, Germany, 10787 Contact: Jörg Neymeyer, Dr. med. 030/26 38-38 01 Principal Investigator: Jörg Neymeyer, Dr. med. Sub-Investigator: Thomas Wülfing, Dr. med. Helios Klinikum Emil von Behring Not yet recruiting Berlin, Germany, 14165 Contact: Kollmeier Jens, Dr. med. 030/81 02-14 47 Sub-Investigator: Jens Kollmeier, Dr. med. Sub-Investigator: Bettina Schlolaut, Dr. med. university hospital of Düsseldorf Recruiting Düsseldorf, Germany, 40255 Contact: Peter Albers, Prof. Dr. med. 0211/811-81 10 Principal Investigator: Peter Albers, Prof. Dr. med. Sub-Investigator: Jasper Decoene Sub-Investigator: Zenginli Hakan Sub-Investigator: Claus F. Eisenberger, Prof. Dr. med. Sub-Investigator: Wolfram T. Knoefel, Prof. Dr. med. Sub-Investigator: Almut Diem university hospital of Essen Recruiting Essen, Germany, 45122 Contact: Herbert Rübben, Prof. Dr. med. 0201/723-32 10 Principal Investigator: Herbert Rübben, Prof. Dr. med. Sub-Investigator: Marcus Schenk, Dr. med. Sub-Investigator: Farnk vom Dorp, Dr. med. Sub-Investigator: Min Ju, Dr. med. Sub-Investigator: Stephan Tschirdewahn Sub-Investigator: Michaela Löbert Ruhrlandklinik Department of Thoracic Surgery Not yet recruiting Essen, Germany, 45239 Contact: Christiane Zimmermann 0201/433-43 24 Sub-Investigator: Georgios Stamatis, Prof. Dr. med. Sub-Investigator: Stefan Welter, Dr. med. Sub-Investigator: Silvia Fechner, Dipl. med. university hospital of Freiburg Recruiting Freiburg, Germany, 79106 Contact: Ulrich Wetterauer, Prof. Dr. med. 0761/270-2891 Principal Investigator: Ulrich Wetterauer, Prof. Dr. med. Sub-Investigator: Christian Leiber, Dr. med. Sub-Investigator: Christian Stremmel, Prof. Dr. med. Sub-Investigator: Jutta Günter, Dr. med. university Hospital of Heidelberg Recruiting Heidelberg, Germany, 69119 Contact: Markus Hohenfellner, Prof. Dr. med. 06221/56-63 21 Principal Investigator: Markus Hohenfellner, Prof. Dr. med. Sub-Investigator: Pahernick Sascha, Priv. Doz. Dr. med. Sub-Investigator: Gencay Hatiboglu, Dr. med. Sub-Investigator: Johannes Huber, Dr. Dr. med. Sub-Investigator: Joachim Pfannschmidt, Priv. Doz. Dr. med. Sub-Investigator: Hendrik Dienemann, Prof. Dr. med. urological hospital of Maria Hilf Krankenhaus Krefeld Recruiting Krefeld, Germany, 47805 Contact: Susanne Krege, Priv. Doz. Dr. med. 02151/334-52 74 Principal Investigator: Susanne Krege, Priv. Doz. Dr. med. Sub-Investigator: Florian Hartmann, Dr. med. Hospital of Großhadern Not yet recruiting München, Germany, 81377 Contact: Michael Staehler, Dr. med. 089/70 95-0 Principal Investigator: Michael Staehler, Dr. med. Sub-Investigator: Cordula Nordhaus, Dr. med. Sub-Investigator: Philipp Nuhn, Dr. med. Sub-Investigator: Hauke Winter, Priv. Doz. Dr. med. Sub-Investigator: Rudolf Hatz, Prof. Dr. med. Sub-Investigator: Sylvia Dondl Dr.-Horst-Schmidt-Kliniken GmbH Recruiting Wiesbaden, Germany, 65199 Contact: Norbert Frickhofen, Prof. Dr. med. 0611/43-30 09 Principal Investigator: Norbert Frickhofen, Prof. Dr. med. Sub-Investigator: Bernd Jung, Dr. med. Sub-Investigator: Heinz G. Fuhr, Dr. med. Sub-Investigator: Joachim Schirren, Prof. Dr. med. Sub-Investigator: Servet Bölükbas, Dr. med. Sub-Investigator: Sabine Labenz Sub-Investigator: Birgit Wilde Sub-Investigator: Klaudia Fischbach 收起 <<
NCT00021528	Depression	Phase 4	Completed	-	-
NCT00080158	Depression Su... 展开 >>icide, Attempted 收起 <<	Phase 2 Phase 3	Completed	-	United States, Maryland ... 展开 >> Johns Hopkins University Baltimore, Maryland, United States, 21287 United States, New York New York University Child Study Center New York, New York, United States, 10016 Columbia University at the New York State Psychiatric Institute New York, New York, United States, 10032 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27705 United States, Pennsylvania University of Pittsburgh - Western Psychiatric Institute and Clinic Pittsburgh, Pennsylvania, United States, 15213 United States, Texas University of Texas, Southwestern Medical Center Dallas, Texas, United States, 75235 收起 <<

Mirtazapine 参考文献

[1]Garcia-Effron G, Gomez-Lopez A, et al. In vitro activity of terbinafine against medically important non-dermatophyte species of filamentous fungi. J Antimicrob Chemother. 2004 Jun;53(6):1086-9. Epub 2004 Apr 21.

[2]Anttila SA, Leinonen EV. A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Rev. 2001 Fall;7(3):249-64.

[3]Anttila SA, Leinonen EV. A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Rev. 2001;7(3):249‐264

[4]Smit M, Dolman KM, Honig A. Mirtazapine in pregnancy and lactation - A systematic review. Eur Neuropsychopharmacol. 2016;26(1):126‐135

[5]Poyurovsky M, Weizman A. Very Low-Dose Mirtazapine (7.5 mg) in Treatment of Acute Antipsychotic-Associated Akathisia. J Clin Psychopharmacol. 2018;38(6):609‐611

[6]Malamood M, Roberts A, Kataria R, Parkman HP, Schey R. Mirtazapine for symptom control in refractory gastroparesis. Drug Des Devel Ther. 2017;11:1035‐1041.

Mirtazapine 实验方案

计算器

存储液制备

1mg

5mg

10mg

1 mM

5 mM

10 mM

3.77mL

0.75mL

0.38mL

18.84mL

3.77mL

1.88mL

37.69mL

7.54mL

3.77mL

Mirtazapine 技术信息

CAS号	85650-52-8
分子式	C₁₇H₁₉N₃
分子量	265.353

别名	米氮平 ;6-Azamianserin;Org3770;Mirtazapine (CRM)
运输	蓝冰

存储条件

液体 -20°C:3-6个月-80°C:12个月

粉末 Sealed in dry,Room Temperature

溶解度

DMSO: 50 mg/mL(188.43 mM)，配合低频超声助溶，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO

动物实验配方

临床研究

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点

NCT01216371	Renal Cell Carcinoma ... 展开 >> Pulmonary Metastases 收起 <<	Phase 2	Unknown	October 2015	Germany ... 展开 >> Universitätsmedizin Charité Berlin Not yet recruiting Berlin, Germany, 10117 Contact: Steffen Weikert, Priv. Doz. Dr. med. 030/84 45-40 84 Principal Investigator: Steffen Weikert, Priv. Doz. Dr. med. Sub-Investigator: Kempkensteffen Carsten, Dr. med. Sub-Investigator: Jonas Busch, Dr. med. Sub-Investigator: Jan Gregor, Dr. med. Sub-Investigator: Jens Neudecker, Dr. med. Sub-Investigator: Jens C. Rückert, Dr. med. Sub-Investigator: Gertrud Feldmann Franziskus Krankenhaus Not yet recruiting Berlin, Germany, 10787 Contact: Jörg Neymeyer, Dr. med. 030/26 38-38 01 Principal Investigator: Jörg Neymeyer, Dr. med. Sub-Investigator: Thomas Wülfing, Dr. med. Helios Klinikum Emil von Behring Not yet recruiting Berlin, Germany, 14165 Contact: Kollmeier Jens, Dr. med. 030/81 02-14 47 Sub-Investigator: Jens Kollmeier, Dr. med. Sub-Investigator: Bettina Schlolaut, Dr. med. university hospital of Düsseldorf Recruiting Düsseldorf, Germany, 40255 Contact: Peter Albers, Prof. Dr. med. 0211/811-81 10 Principal Investigator: Peter Albers, Prof. Dr. med. Sub-Investigator: Jasper Decoene Sub-Investigator: Zenginli Hakan Sub-Investigator: Claus F. Eisenberger, Prof. Dr. med. Sub-Investigator: Wolfram T. Knoefel, Prof. Dr. med. Sub-Investigator: Almut Diem university hospital of Essen Recruiting Essen, Germany, 45122 Contact: Herbert Rübben, Prof. Dr. med. 0201/723-32 10 Principal Investigator: Herbert Rübben, Prof. Dr. med. Sub-Investigator: Marcus Schenk, Dr. med. Sub-Investigator: Farnk vom Dorp, Dr. med. Sub-Investigator: Min Ju, Dr. med. Sub-Investigator: Stephan Tschirdewahn Sub-Investigator: Michaela Löbert Ruhrlandklinik Department of Thoracic Surgery Not yet recruiting Essen, Germany, 45239 Contact: Christiane Zimmermann 0201/433-43 24 Sub-Investigator: Georgios Stamatis, Prof. Dr. med. Sub-Investigator: Stefan Welter, Dr. med. Sub-Investigator: Silvia Fechner, Dipl. med. university hospital of Freiburg Recruiting Freiburg, Germany, 79106 Contact: Ulrich Wetterauer, Prof. Dr. med. 0761/270-2891 Principal Investigator: Ulrich Wetterauer, Prof. Dr. med. Sub-Investigator: Christian Leiber, Dr. med. Sub-Investigator: Christian Stremmel, Prof. Dr. med. Sub-Investigator: Jutta Günter, Dr. med. university Hospital of Heidelberg Recruiting Heidelberg, Germany, 69119 Contact: Markus Hohenfellner, Prof. Dr. med. 06221/56-63 21 Principal Investigator: Markus Hohenfellner, Prof. Dr. med. Sub-Investigator: Pahernick Sascha, Priv. Doz. Dr. med. Sub-Investigator: Gencay Hatiboglu, Dr. med. Sub-Investigator: Johannes Huber, Dr. Dr. med. Sub-Investigator: Joachim Pfannschmidt, Priv. Doz. Dr. med. Sub-Investigator: Hendrik Dienemann, Prof. Dr. med. urological hospital of Maria Hilf Krankenhaus Krefeld Recruiting Krefeld, Germany, 47805 Contact: Susanne Krege, Priv. Doz. Dr. med. 02151/334-52 74 Principal Investigator: Susanne Krege, Priv. Doz. Dr. med. Sub-Investigator: Florian Hartmann, Dr. med. Hospital of Großhadern Not yet recruiting München, Germany, 81377 Contact: Michael Staehler, Dr. med. 089/70 95-0 Principal Investigator: Michael Staehler, Dr. med. Sub-Investigator: Cordula Nordhaus, Dr. med. Sub-Investigator: Philipp Nuhn, Dr. med. Sub-Investigator: Hauke Winter, Priv. Doz. Dr. med. Sub-Investigator: Rudolf Hatz, Prof. Dr. med. Sub-Investigator: Sylvia Dondl Dr.-Horst-Schmidt-Kliniken GmbH Recruiting Wiesbaden, Germany, 65199 Contact: Norbert Frickhofen, Prof. Dr. med. 0611/43-30 09 Principal Investigator: Norbert Frickhofen, Prof. Dr. med. Sub-Investigator: Bernd Jung, Dr. med. Sub-Investigator: Heinz G. Fuhr, Dr. med. Sub-Investigator: Joachim Schirren, Prof. Dr. med. Sub-Investigator: Servet Bölükbas, Dr. med. Sub-Investigator: Sabine Labenz Sub-Investigator: Birgit Wilde Sub-Investigator: Klaudia Fischbach 收起 <<
NCT00021528	Depression	Phase 4	Completed	-	-
NCT00080158	Depression Su... 展开 >>icide, Attempted 收起 <<	Phase 2 Phase 3	Completed	-	United States, Maryland ... 展开 >> Johns Hopkins University Baltimore, Maryland, United States, 21287 United States, New York New York University Child Study Center New York, New York, United States, 10016 Columbia University at the New York State Psychiatric Institute New York, New York, United States, 10032 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27705 United States, Pennsylvania University of Pittsburgh - Western Psychiatric Institute and Clinic Pittsburgh, Pennsylvania, United States, 15213 United States, Texas University of Texas, Southwestern Medical Center Dallas, Texas, United States, 75235 收起 <<
NCT00612807	Major Depressive Disorder ... 展开 >> Partner Relational Disorder (V61.10) 收起 <<	Phase 1 Phase 2	Completed	-	United States, North Carolina ... 展开 >> Duke Child & Family Studies Center; Duke University Medical Center Durham, North Carolina, United States, 27705 收起 <<
NCT01555086	Prostate Cancer	Not Applicable	Recruiting	-	Germany ... 展开 >> Krankenhaus Maria Hilf Recruiting Krefeld, Dießemer Bruch 80, Germany, 47805 Contact: Michel Kämper 02151 / 334-5248 M.Kaemper@alexianer.de Martiniklinik am UKE Recruiting Hamburg, Martinistraße 52, Germany, 20246 Contact: Anneta Malamateniou 040/74 10 51 311 malamateniou@martini-klinik.de St. Antonius-Krankenhaus Recruiting Gronau, Möllenweg 22, Germany, 48599 Contact: Günter Gust 02562/915-77 80 gust@st-antonius-gronau.de Städtisches Klinikum Fulda Recruiting Fulda, Pacelliallee 3-5, Germany, 36043 Contact: Matthias Schieber, Dr. Matthias.Schieber@klinikum-fulda.de RWTH Aachen Recruiting Aachen, Pauwelsstraße 30, Germany, 51074 Contact: Sandra Richlowski 0241/80-35 358 srichlowski@ukaachen.de 收起 <<
NCT00612807	-		Completed	-	-
NCT00564278	-		Completed	-	-
NCT02400346	Major Depression Disorder	Phase 3	Completed	-	-
NCT00564278	Depression	Not Applicable	Completed	-	United States, New York ... 展开 >> New York State Psychiatric Institute, 1051 Riverside Drive New York, New York, United States, 10032 收起 <<
NCT01944657	1. Major Depressive Disorder	Not Applicable	Withdrawn(unable to enroll sub... 展开 >>jects) 收起 <<	December 2015	United States, Maryland ... 展开 >> Sheppard Pratt Health System Towson, Maryland, United States, 21204 收起 <<
NCT02400346	-		Completed	-	-
NCT02058693	Major Depressive Disorder	Phase 4	Completed	-	United States, Illinois ... 展开 >> Rush University Medical Center Chicago, Illinois, United States, 60612 收起 <<
NCT02893371	-		Enrolling by invitation	June 2019	United States, New Mexico ... 展开 >> Christophe G Lambert Albuquerque, New Mexico, United States, 87131 收起 <<
NCT00704860	Major Depression	Phase 4	Completed	-	Canada, Ontario ... 展开 >> University of Ottawa Institute of Mental Health Research Ottawa, Ontario, Canada, K1Z 7K4 收起 <<
NCT00057551	Depression De... 展开 >>pressive Disorder 收起 <<	Phase 4	Completed	-	United States, Arizona ... 展开 >> University of Arizona Tucson, Arizona, United States, 85724-5002 United States, California Stanford University Palo Alto, California, United States, 94305 United States, Georgia Emory University Atlanta, Georgia, United States, 30329 United States, New York Weill-Cornell Medical College Payne Whitney Clinic New York, New York, United States, 10021 SUNY- Stony Brook New York, New York, United States, 11794 United States, Pennsylvania University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213-2600 United States, Rhode Island Brown University Providence, Rhode Island, United States, 02906 United States, Texas University of Texas Southwestern Medical Center Dallas, Texas, United States, 75235 收起 <<
NCT01943435	Lumbar Spinal Stenosis	Not Applicable	Completed	-	United States, Pennsylvania ... 展开 >> UPMC Shadyside Center for Integrative Medicine Pittsburgh, Pennsylvania, United States, 15232 收起 <<
NCT00742573	Major Depressive Disorder	Phase 2	Active, not recruiting	January 2019	United States, New York ... 展开 >> New York State Psychiatric Institute New York, New York, United States, 10032 收起 <<
NCT00057551	-		Completed	-	-
NCT02809677	Asthma Major ... 展开 >>Depressive Disorder 收起 <<	Phase 4	Recruiting	June 2019	United States, Texas ... 展开 >> University of Texas Southwestern Medical Center Psychoneuroendocrine Research Program Recruiting Dallas, Texas, United States, 75235 Contact: Traci Holmes, B.A. 214-645-6959 traci.holmes@utsouthwestern.edu Principal Investigator: Edson S Brown, M.D., PhD 收起 <<
NCT00759993	Weight Gain O... 展开 >>besity 收起 <<	Phase 2	Terminated(inability to recrui... 展开 >>t and retain) 收起 <<	March 2013	-
NCT01962753	Elderly Major... 展开 >> Depression 收起 <<	Not Applicable	Unknown	May 2018	France ... 展开 >> University Hospital of Besançon- Jean Minjoz Recruiting Besançon, France, 25030 Contact: Pierre VANDEL pierre.vandel@univ-fcomte.fr University Hospital of Caen Recruiting Caen, France, 14000 Contact: Sonia DOLLFUS dollfus-s@chu-caen.fr University Hospital of Lille Recruiting Lille, France, 59000 Contact: Jean ROCHE Jean.ROCHE@CHRU-LILLE.FR University Hospital of Nice Recruiting Nice, France, 06000 Contact: Philippe ROBERT robert.p@chu-nice.fr Sainte-Anne Hospital Recruiting Paris, France, 75014 Contact: Thierry GALLARDA T.GALLARDA@ch-sainte-anne.fr Le Rouvray Hospital Recruiting Sotteville lès Rouen, France, 76300 Contact: Marie DESBORDES marie.desbordes@ch-lerouvray.fr University Hospital of Strasbourg - HUS Recruiting Strasbourg, France, 67098 Contact: Frédéric BLANC frederic.blanc@chru-strasbourg.fr University Hospital of Toulouse - Purpan Recruiting Toulouse, France, 31059 Contact: Christophe ARBUS arbus.c@chu-toulouse.fr University Hospital of Tours Recruiting Tours, France, 37000 Contact: Vincent CAMUS vincent.camus@univ-tours.fr 收起 <<
NCT01943435	-		Completed	-	-
NCT00926835	Major Depressive Disorder	Phase 4	Terminated(due to patient recr... 展开 >>uitment difficulties) 收起 <<	-	Korea, Republic of ... 展开 >> Clinical research center for depression Seoul, Korea, Republic of, 150713 收起 <<
NCT02560324	Tobacco Use Disorder	Phase 2	Completed	-	United States, Pennsylvania ... 展开 >> Center for Interdisciplinary Research on Nicotine Addiction, School of Medicine, University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 收起 <<
NCT00287352	Psychotic Disorder ... 展开 >> Schizophreniform Disorder Schizophrenia Schizoaffective Disorder Mood Disorders With Psychotic Features 收起 <<	Phase 1	Completed	-	United States, North Carolina ... 展开 >> University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States, 27599 收起 <<
NCT01813656	Methamphetamine Dependence	Phase 4	Terminated(Aripiprazole arm ha... 展开 >>d obvious adverse reactions,especially akathisia.) 收起 <<	-	China, Hunan ... 展开 >> The Second Xiangya Hospital of Central University Changsha, Hunan, China, 410011 收起 <<
NCT03377660	-		Enrolling by invitation	January 2019	Ireland ... 展开 >> Conway Institute, UCD Dublin, Ireland 收起 <<
NCT01932931	Major Depression ... 展开 >> Osteoporosis 收起 <<	Not Applicable	Completed	-	Denmark ... 展开 >> Aalborg University Aalborg, North Jutland, Denmark, 9000 CCBR Aalborg, North Jutland, Denmark, 9000 收起 <<
NCT01352572	Depression	Not Applicable	Unknown	December 2018	Korea, Republic of ... 展开 >> Samsung Medical Center Kangnam, Seoul, Korea, Republic of, 135-710 收起 <<
NCT01896349	Treatment Resistant Depression	Not Applicable	Unknown	November 2014	Brazil ... 展开 >> Federal University of Rio Grande do Sul / Hospital de Clínicas de Porto Alegre (HCPA) Recruiting Porto Alegre, RS, Brazil, 90035-003 Contact: Lívia H Souza, MD +55 5198658701 livia.hs@terra.com.br Contact: Marcelo PA Fleck, MD, PhD +55 51 33598294 mfleck.voy@terra.com.br Sub-Investigator: Lívia H Souza, MD Principal Investigator: Marcelo PA Fleck, MD, PhD Sub-Investigator: Marco Antonio K Caldieraro, MD, MSc Sub-Investigator: Lucas Spanemberg, MD Sub-Investigator: Edgar A Vares, MD 收起 <<
NCT00817011	Depression An... 展开 >>tidepressant Drug Adverse Reaction 收起 <<	Not Applicable	Unknown	March 2018	Korea, Republic of ... 展开 >> Samsung Medical Center Recruiting Kangnam, Seoul, Korea, Republic of, 135-710 Contact: DohKwan Kim Principal Investigator: Doh Kwan Kim, ph.D, M.D. 收起 <<
NCT00953108	Major Depression	Phase 3	Completed	-	Germany ... 展开 >> Department of Psychiatry, Ludwig-Maximilian-University Munich, Bavaria, Germany, 80336 收起 <<
NCT02711215	Major Depressive Disorder	Phase 4	Recruiting	March 2019	Austria ... 展开 >> Department of Psychiatry and Psychotherapy, Medical University of Vienna Recruiting Vienna, Austria, 1090 Contact: Rupert Lanzenberger, A/Prof. +43 40400 ext 35760 rupert.lanzenberger@meduniwien.ac.at Principal Investigator: Rupert Lanzenberger, A/Prof. MD 收起 <<
NCT03219008	Depressive Disorder	Phase 4	Recruiting	December 2020	China ... 展开 >> ShanghaiMHC Recruiting Shanghai, China 收起 <<
NCT00732901	Cocaine Dependence	Phase 2 Phase 3	Completed	-	United States, Texas ... 展开 >> University of Texas Health Science Center-Houston; Substance Abuse Research Clinic Houston, Texas, United States, 77030 收起 <<
NCT00817375	Depression Ad... 展开 >>verse Reaction to Drug 收起 <<	Not Applicable	Unknown	December 2018	Korea, Republic of ... 展开 >> Samsung Medical Center Recruiting Kangnam, Seoul, Korea, Republic of, 135-710 Contact: Samsung Medical Center Kim, MD.pHD 82-2-3410-3582 dohkwan.kim@samsung.com 收起 <<
NCT01228357	Depression De... 展开 >>pressive Symptoms 收起 <<	Not Applicable	Unknown	December 2018	Korea, Republic of ... 展开 >> Samsung Medical Center Recruiting Kangnam, Seoul, Korea, Republic of Contact: Doh Kwan Kim, MD.PhD 82-2-3410-3582 dohkwan.kim@samsung.com Contact: Woojae Myung, MD. 82-2-3410-6562 smbhealer@gmail.com 收起 <<
NCT00732901	-		Completed	-	-
NCT01421342	Major Depressive Disorder	Phase 3	Completed	-	-
NCT01764867	Major Depressive Disorder	Phase 4	Unknown	December 2014	China ... 展开 >> Shanghai Mental Health Center Recruiting Shanghai, China, 200030 Contact: Zhiguo Wu, M.D. 862134289888 ext 3528 wu_zhiguo@yahoo.com.cn Principal Investigator: Yiru Fang, Ph.D., M.D. 收起 <<
NCT01421342	-		Completed	-	-
NCT03148522	Diagnosis and Treatment of Dep... 展开 >>ression 收起 <<	Phase 4	Not yet recruiting	December 30, 2021	-
NCT02228239	Healthy	Phase 1	Completed	-	Netherlands ... 展开 >> Leiden, Netherlands 收起 <<
NCT00590863	Major Depressive Disorder	Phase 4	Completed	-	United States, Alabama ... 展开 >> Tuscalossa VA Mental Health Clinic Tuscaloosa, Alabama, United States, 35404 United States, California Harbor UCLA Family Health Care Center Harbor City, California, United States, 90710 UCLA Internal Medicine Clinic Los Angeles, California, United States, 90024 Veterans Affairs Medical Center/FIRM Primary Care Clinic San Diego, California, United States, 92161 United States, Illinois Northwestern Psychiatric Outpatient Treatment Care Center Chicago, Illinois, United States, 60611 United States, Kansas Clinical Research Institute Wichita, Kansas, United States, 67214 United States, Massachusetts MGH/Northshore Medical Center (Salem Psychiatric Facility) Salem, Massachusetts, United States, 01970 United States, Michigan General Psychiatric Ambulatory Clinic Ann Arbor, Michigan, United States, 48105 United States, New York Irving Goldman Primary Care at North Shore Hospital New York, New York, United States, 11040 United States, North Carolina UNC Chapel Hill Adult Diagnostic & Treatment Clinic Chapel Hill, North Carolina, United States, 27599-7160 United States, Oklahoma Laureate Psychiatric Clinic and Hospital Tulsa, Oklahoma, United States, 74135 United States, Pennsylvania Bellefield Clinic of WPIC Pittsburgh, Pennsylvania, United States, 15213 United States, Tennessee Vine Hill Community Clinic Nashville, Tennessee, United States, 37212 United States, Texas UT Southwestern Family Medicine Clinic Dallas, Texas, United States, 75390 United States, Virginia VCU Outpatient Psychiatry Clinic Richmond, Virginia, United States, 23298 收起 <<
NCT02456948	Major Depressive Disorder	Phase 2	Recruiting	February 2019	Germany ... 展开 >> Heidelberg University Hospital, Department of Psychiatry Recruiting Heidelberg, Baden-Württemberg, Germany, 69115 Contact: Egle Simulionyte, MD +49-(0)6221-56-5472 Principal Investigator: Oliver Gruber, MD Sub-Investigator: Daniela Roesch-Ely, MD Department of Psychiatry, Universitiy Hospital Recruiting Erlangen, Bavaria, Germany, 91054 Contact: Johannes Kornhuber, MD +49 (0)9131 85-33001 Principal Investigator: Johannes Kornhuber, MD Sub-Investigator: Juan Manuel Maler, MD Department of Psychiatry, LMU Munich Recruiting Munich, Bavaria, Germany, 80336 Contact: Thomas Görlitz +49 (0)89-4400-55861 thomas.goerlitz@med.uni-muenchen.de Principal Investigator: Cornelius Schüle, MD Sub-Investigator: Frank Padberg, MD Max Planck Institute of Psychiatry Recruiting Munich, Bavaria, Germany, 80804 Contact: Marcus Ising, PG +49 (0)89 306221 ising@psych.mpg.de Contact: , MD Principal Investigator: Martin Keck, MD Sub-Investigator: Susanne Lucae, MD Department of Psychiatry, Universitiy Hospital Recruiting Regensburg, Bavaria, Germany, 93053 Contact: Thomas Baghai, MD +449 (0)941 941-1004 Principal Investigator: Thomas Baghai, MD Sub-Investigator: Thomas Wetter, MD Department of Psychiatry, University Medical Center Göttingen Recruiting Göttingen, Lower Saxony, Germany, 37075 Contact: Roberto Goya-Maldonado, MD +49 (0) 551 39-22244 roberto.goya@med.uni-goettingen.de Principal Investigator: Roberto Goya-Maldonado, MD Sub-Investigator: Jens Wiltfang, MD Department of Psychiatry, Charité - Campus Benjamin Franklin Recruiting Berlin, Germany, 12203 Contact: Julian Hellmann, MD Julian.Hellmann@charite.de Contact: Vera Clemens, MD Vera.Clemens@charite.de Principal Investigator: Isabella Heuser, MD, PhD 收起 <<
NCT00798395	Sleep Initiation and Maintenan... 展开 >>ce Disorders Mental Disorders 收起 <<	Phase 1	Completed	-	-
NCT02441387	-		Active, not recruiting	July 2019	Brazil ... 展开 >> University of São Paulo, Faculty of Medicine, Institute and Department of Psychiatry São Paulo, Brazil, 05403-010 收起 <<
NCT00385437	Depression Ex... 展开 >>cessive Daytime Sleepiness 收起 <<	Phase 2	Completed	-	Canada, Ontario ... 展开 >> University Health Network Toronto, Ontario, Canada, M5T 2S8 收起 <<
NCT00590863	-		Completed	-	-
NCT00108498	Obstructive Sleep Apnea	Phase 1	Completed	-	United States, Florida ... 展开 >> Malcom Randall VAMC Gainesville, Florida, United States, 32608 收起 <<
NCT01497548	Depression	Phase 3	Unknown	October 2012	Malaysia ... 展开 >> University Malaya Medical Centre Recruiting Kuala Lumpur, Malaysia, 50603 Contact: Chong Guan Ng, MBBS, MPM 0379492068 chong_guan1975@yahoo.co.uk University Malaya Medical Centre Not yet recruiting Kuala Lumpur, Malaysia, 59100 Contact: Chong Guan Ng, MBBS, MPM 60379604367 chong_guan@hotmail.com Principal Investigator: Chong Guan Ng, MBBS, MPM 收起 <<
NCT01109693	Unipolar Major Depressive Epis... 展开 >>ode 收起 <<	Phase 4	Completed	-	Japan ... 展开 >> Nagoya City University Hospital Nagoya, Aichi, Japan, 467-8602 Kochi Medical School Hospital Nangoku, Kochi, Japan, 783-8505 收起 <<
NCT00150839	Depressive Disorder, Major	Phase 4	Unknown	December 2009	Germany ... 展开 >> Department of Psychiatry and Psychotherapy, University Erlangen-Nuremberg Recruiting Erlangen, Bavaria, Germany, 91054 Contact: Stefan Bleich, MD 004991318534262 stefan.bleich@uk-erlangen.de Principal Investigator: Stefan Bleich, MD Sub-Investigator: Julia Wilhelm, MD Sub-Investigator: Helge Frieling, MD 收起 <<
NCT00750919	Sleep Initiation and Maintenan... 展开 >>ce Disorders Mental Disorders Dyssomnias Sleep Disorders Sleep Disorders, Intrinsic 收起 <<	Phase 3	Terminated(This trial was stop... 展开 >>ped prematurely due to the Sponsor's decision not to continue the development of esmertazapine for this indication.) 收起 <<	-	-
NCT00561821	-		Completed	-	-
NCT00750919	-		Terminated(This trial was stop... 展开 >>ped prematurely due to the Sponsor's decision not to continue the development of esmertazapine for this indication.) 收起 <<	-	-
NCT02191124	Major Depressive Disorder	Phase 4	Completed	-	China, Beijing ... 展开 >> Beijing Anding Hospital Beijing, Beijing, China, 100088 收起 <<
NCT00561821	Insomnia Slee... 展开 >>p Initiation and Maintenance Disorders Mental Disorders Dyssomnias Sleep Disorders 收起 <<	Phase 3	Completed	-	-
NCT00631657	-		Completed	-	-
NCT00631657	Sleep Initiation and Maintenan... 展开 >>ce Disorders Mental Disorders Dyssomnias Sleep Disorders Sleep Disorder, Intrinsic 收起 <<	Phase 3	Completed	-	-
NCT01725048	Major Depressive Disorder ... 展开 >> Neoplasms 收起 <<	Early Phase 1	Completed	-	United States, North Carolina ... 展开 >> University of North Carolina Hospital Chapel Hill, North Carolina, United States, 27599 收起 <<
NCT00561574	Sleep Initiation and Maintenan... 展开 >>ce Disorder; Elderly Mental Disorder Dyssomnias Sleep Disorders Sleep Disorder, Intrinsic 收起 <<	Phase 3	Completed	-	-
NCT00561574	-		Completed	-	-
NCT01119924	Depression Pa... 展开 >>in 收起 <<	Phase 4	Completed	-	Taiwan ... 展开 >> Nang Kuang Pharmaceutical Co., LTD Tainan, Xinhua Township, Taiwan 收起 <<
NCT00535288	Postmenopausal Symptoms ... 展开 >> Menopause Vasomotor Symptoms 收起 <<	Phase 3	Completed	-	-
NCT00560833	Menopause Vas... 展开 >>omotor Symptoms 收起 <<	Phase 3	Completed	-	-
NCT00560833	-		Completed	-	-
NCT00834197	Healthy	Phase 1	Completed	-	United States, North Dakota ... 展开 >> PRACS Institute, Ltd. Fargo, North Dakota, United States, 58104 收起 <<
NCT00610675	-		Completed	-	-
NCT00835575	Healthy	Phase 1	Completed	-	United States, North Dakota ... 展开 >> PRACS Institute, Ltd. Fargo, North Dakota, United States, 58104 收起 <<
NCT00835575	-		Completed	-	-
NCT00535288	-		Completed	-	-
NCT00482612	Insomnia	Phase 3	Completed	-	-
NCT00610675	Insomnia	Phase 3	Completed	-	-
NCT02646449	Major Depressive Disorder ... 展开 >> Alcohol Use Disorder 收起 <<	Phase 2	Completed	-	United States, Pennsylvania ... 展开 >> Western Psychiatric Institute and Clinic Pittsburgh, Pennsylvania, United States, 15213 收起 <<
NCT00482612	-		Completed	-	-
NCT00506389	Insomnia	Phase 3	Completed	-	-
NCT02646449	-		Completed	-	-
NCT00834197	-		Completed	-	-
NCT01505504	-		Completed	-	Belgium ... 展开 >> CHU Brugmann Brussels, Belgium, 1020 收起 <<
NCT00874003	Alcohol Dependence	Phase 2	Completed	-	Sweden ... 展开 >> Addiction Biology Unit Gothenburg, Sweden, 413 45 收起 <<
NCT00782405	Sleep	Phase 3	Completed	-	Germany ... 展开 >> Sleep Disorders Center Munich, Bavaria, Germany, 81675 收起 <<
NCT00288782	Mental Disorders ... 展开 >> Mood Disorders Affective Disorders Depressive Disorders 收起 <<	Phase 4	Completed	-	Denmark ... 展开 >> Center for Psychiatric Research, Psychiatric Hospital of Aarhus University Risskov, Denmark, 8240 收起 <<
NCT01178671	Posttraumatic Stress Disorder	Phase 4	Completed	-	United States, New York ... 展开 >> Anxiety Disorders Clinic, New York State Psychiatric Institute New York, New York, United States, 10032 收起 <<
NCT00322309	Cocaine Dependence ... 展开 >> Depression 收起 <<	Phase 2	Completed	-	United States, Massachusetts ... 展开 >> Boston University Boston, Massachusetts, United States, 02118 收起 <<
NCT01302964	Autism Spectrum Disorders	Phase 3	Completed	-	United States, Indiana ... 展开 >> Riley Child and Adolescent Psychiatry Clinic Riley Hospital Indianapolis, Indiana, United States, 46202 United States, Massachusetts Lurie Center -MassGeneral Hospital Lexington, Massachusetts, United States, 02421 收起 <<
NCT00506389	-		Completed	-	-
NCT00322309	-		Completed	-	-
NCT01501396	Anorexia	Phase 2	Withdrawn	September 2015	-
NCT01302964	-		Completed	-	-
NCT00249444	Cocaine Dependence ... 展开 >> Depression 收起 <<	Phase 2	Completed	-	United States, New York ... 展开 >> Research Foundation for Mental Hygiene, Inc. New York, New York, United States, 10032 收起 <<
NCT00488072	Advanced Cancer ... 展开 >> Anorexia Weight Loss Insomnia 收起 <<	Phase 2	Active, not recruiting	January 2020	United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 <<
NCT03675555	Shivering	Phase 4	Completed	-	Egypt ... 展开 >> Ibrahim Mamdouh Esmat Heliopolis, Cairo, Egypt, 11361 收起 <<
NCT00249444	-		Completed	-	-
NCT00302107	-		Completed	-	-
NCT03031184	Dementia	Phase 3	Recruiting	July 2020	United Kingdom ... 展开 >> Sube Banerjee Recruiting Brighton, Sussex, United Kingdom, BN1 9RY Contact: Sube Banerjee, MD 01273877896 s.banerjee@bsms.ac.uk Principal Investigator: Naji Tabet, MD Principal Investigator: Chris Fox, MD Principal Investigator: Alan Thomas, MD Principal Investigator: Ross Dunne, MD Principal Investigator: Gill Livingston, MD Principal Investigator: Peter Bentham, MD Principal Investigator: Annabel Price, MD Principal Investigator: Ramin Nilforooshan, MD Principal Investigator: Carol Bannister, MD Principal Investigator: Sushanth Kamath, MD 收起 <<
NCT00302107	Anxiety PTSD	Phase 4	Completed	-	United States, Alabama ... 展开 >> Tuscaloosa VAMC Tuscaloosa, Alabama, United States, 35405 收起 <<
NCT01178671	-		Completed	-	-
NCT00497081	Substance Abuse ... 展开 >> HIV Infections 收起 <<	Phase 2	Completed	-	United States, California ... 展开 >> San Francisco Department of Public Health, Substance Use Research Unit San Francisco, California, United States, 94102 收起 <<
NCT00960830	Depression An... 展开 >>xiety 收起 <<	Not Applicable	Completed	-	Argentina ... 展开 >> Cl Sn Nicol San Nicolas, Bs As, Argentina, 1900 收起 <<
NCT00865696	Healthy	Phase 1	Completed	-	United States, North Dakota ... 展开 >> PRACS Institute, Ltd. Fargo, North Dakota, United States, 58102 收起 <<
NCT00497081	-		Completed	-	-
NCT00600145	Amphetamine Dependence	Not Applicable	Withdrawn(PI decision)	July 2010	United States, Virginia ... 展开 >> Universiyt of Virginia Charlottesville, Virginia, United States, 22908 收起 <<
NCT02336750	Breast Cancer	Phase 3	Recruiting	December 2019	China ... 展开 >> Fudan University Cancer Hospital Recruiting Shanghai, China, 200032 Contact: Xichun Hu, MD,PhD 64175590 ext 5006 huxicun@gmail.com Contact: Jun Cao, MD 64175590 ext 5009 caojun1115lemon@163.com 收起 <<
NCT01165541	-		Completed	-	-
NCT00865384	Healthy	Phase 1	Completed	-	United States, North Dakota ... 展开 >> PRACS Institute, Ltd. Fargo, North Dakota, United States, 58102 收起 <<
NCT01598584	Pancreatic Cancer	Phase 2 Phase 3	Withdrawn(Gemcitabine is not t... 展开 >>he first choice for most pancreatic cancer patients nowdays) 收起 <<	December 2015	China, Tianjin ... 展开 >> TianjinCIH Tianjin, Tianjin, China, 300060 收起 <<
NCT03679052	Shivering	Phase 4	Completed	-	Egypt ... 展开 >> Ibrahim Mamdouh Esmat Heliopolis, Cairo, Egypt, 11361 收起 <<
NCT00919295	Fibromyalgia Syndrome	Phase 2	Completed	-	Thailand ... 展开 >> Siriraj Hospital, Mahidol University Bangkoknoi, Bangkok, Thailand, 10700 收起 <<
NCT01458626	Major Depression	Phase 4	Completed	-	China, Beijing ... 展开 >> Beijing Anding Hospital Beijing, Beijing, China, 100088 收起 <<
NCT01263080	Schizophrenia	Phase 4	Completed	-	China, Beijing ... 展开 >> Beijing Anding Hospital, Capital Medical University Beijing, Beijing, China, 100088 收起 <<
NCT02541526	Heroin Dependence ... 展开 >> Amphetamine Dependence 收起 <<	Phase 3	Unknown	May 2017	Malaysia ... 展开 >> University Science Malaysia Recruiting Kota bharu, Kelantan, Malaysia, 16010 Contact: Vicknasingam B Kasinather, PhD 6046532140 vickna@usm.my Contact: Imran Ahmad 6097676603 profimran@usm.my 收起 <<
NCT01465919	Depression	Phase 4	Terminated(Due to the recent c... 展开 >>hange in standard of care for hepatitis C.) 收起 <<	-	Korea, Republic of ... 展开 >> SMG-SNU Boramae Medical Center Seoul, Korea, Republic of, 156-707 收起 <<
NCT00832520	-		Terminated(Low accrual rate.)	-	-
NCT01039740	Depression	Not Applicable	Unknown	December 2018	Korea, Republic of ... 展开 >> Samsung Medical Center Recruiting Kangnam, Seoul, Korea, Republic of, 135-710 Contact: Samsung Medical Center Kim, phD, MD 82-2-3410-3582 dohkwan.kim@samsung.com 收起 <<
NCT00878540	Healthy	Phase 1	Completed	-	Germany ... 展开 >> Max Planck Institue of Psychiatry Munich, Germany 收起 <<
NCT01165541	Alcohol Dependence	Phase 2	Completed	-	United States, New Hampshire ... 展开 >> Dartmouth Medical School Department of Psychiatry's Addition Research Center Bedford, New Hampshire, United States, 03110 Dartmouth Medical School Department of Psychiatry's Addiction Research Center Hanover, New Hampshire, United States, 03755 收起 <<
NCT02185131	Major Depressive Disorder ... 展开 >> Alcohol Use Disorder 收起 <<	Phase 2	Completed	-	United States, Pennsylvania ... 展开 >> Western Psychiatric Institute and Clinic Pittsburgh, Pennsylvania, United States, 15213 收起 <<
NCT02185131	-		Completed	-	-
NCT01240096	Functional Dyspepsia	Phase 4	Unknown	December 2011	Belgium ... 展开 >> University Hospitals Recruiting Leuven, Vlaanderen, Belgium, 3000 Contact: Jan Tack, M.D., Ph.D. +3216344225 jan.tack@med.kuleuven.be Principal Investigator: Jan Tack, M.D., Ph.D. 收起 <<
NCT00832520	Advanced Cancer	Phase 2	Terminated(Low accrual rate.)	-	United States, New Mexico ... 展开 >> University of New Mexico Cancer Center @ Lovelace Medical Center Albuquerque, New Mexico, United States, 87102 Universtiy of New Mexico - Cancer Center Albuquerque, New Mexico, United States, 87106 收起 <<
NCT01949571	Drug-withdrawal. ... 展开 >> Drug Abuse Drug-induced Depressive State AOD Craving AODR Depressive State 收起 <<	Phase 2	Completed	-	Mexico ... 展开 >> National Institute of Psychiatry México. Distrito Federal, Distrito Federal, Mexico, 14370 收起 <<
NCT01867775	Alzheimer's Disease ... 展开 >> Sleep Disorders 收起 <<	Phase 3	Unknown	May 2014	Brazil ... 展开 >> Brasilia University Recruiting Brasilia, Distrito Federal, Brazil, 70840 Contact: Francisca M Scoralick franciscascoralick@gmail.com Sub-Investigator: Francisca M Scoralick 收起 <<
NCT03254173	Advanced Cancer ... 展开 >> Cancer Associated Anorexia - Cachexia 收起 <<	Phase 2 Phase 3	Not yet recruiting	August 1, 2018	-
NCT03283488	Cachexia; Cancer ... 展开 >> Anorexia 收起 <<	Phase 3	Not yet recruiting	December 30, 2020	Brazil ... 展开 >> Clinics Hospital, Ribeirão Preto Medical School, University of São Paulo Not yet recruiting Ribeirão Preto, São Paulo, Brazil, 14048900 Contact: Nereida KC Lima, MD, PhD +5516992770522 nereida@fmrp.usp.br 收起 <<
NCT01888835	Amphetamine-Related Disorders	Phase 2	Completed	-	United States, California ... 展开 >> Substance Use Research Unit San Francisco, California, United States, 94102 收起 <<
NCT01601002	Major Depressive Disorder	Phase 4	Completed	-	Canada, Ontario ... 展开 >> London Health Sciences Centre London, Ontario, Canada, N6A 5W9 收起 <<
NCT02650544	Carcinoma, Non-Small-Cell Lung... 展开 >> Depression 收起 <<	Phase 2	Active, not recruiting	June 2019	China, Guangdong ... 展开 >> Cancer Center of Sun-Yat Sen University (CCSYSU) GuangZhou, Guangdong, China, 510060 收起 <<
NCT01825928	Methamphetamine Dependence	Not Applicable	Completed	-	China, Hunan ... 展开 >> The Second Xiangya Hospital of Central University Changsha, Hunan, China, 410011 收起 <<

米尔塔扎平 /Mirtazapine {[allProObj[0].p_purity_real_show]}

Mirtazapine 纯度/质量文件产品仅供科研

全球学术期刊中引用的产品

Mirtazapine 质控信息

Mirtazapine 生物活性

Mirtazapine 临床研究

Mirtazapine 参考文献

Mirtazapine 实验方案

Mirtazapine 技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

米尔塔扎平 /Mirtazapine {[allProObj[0].p_purity_real_show]}

Mirtazapine 纯度/质量文件 产品仅供科研

全球学术期刊中引用的产品

Mirtazapine 质控信息

Mirtazapine 生物活性

Mirtazapine 临床研究

Mirtazapine 参考文献

Mirtazapine 实验方案

Mirtazapine 技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

请登录您的专属账户

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

Mirtazapine 纯度/质量文件产品仅供科研